Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2Genitourinary 2Endocrine 2Breast 2Sarcoma 1NET 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Neuroendocrine Tumors 1Carcinoma, Neuroendocrine 1

Interventions

Surveys and Questionnaires 8Blood Specimen Collection 7lutetium Lu 177 dotatate 6Surgical Procedures, Operative 6Magnetic Resonance Spectroscopy 6Adrenalectomy 5Observation 4Transurethral Resection of Prostate 3Thyroidectomy 3Positron-Emission Tomography 3Lymph Node Excision 3Data Collection 3telotristat ethyl 2surufatinib 2gallium Ga 68 dotatate 2Somatostatin 2Radionuclide Imaging 2Radiofrequency Ablation 2Everolimus 2Drug Therapy 2Biopsy 2somapacitan 1methyl hydroxyethyl cellulose 1lanreotide 1fluorodopa F 18 1exemestane 1delta 24-sterol reductase 1copper dotatate CU-64 1Whole Body Imaging 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Radionuclide Imaging × Endocrine × Clear all
NCT04069299 2026-03-31

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

H. Lee Moffitt Cancer Center and Research Institute

Completed
30 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT06448208 2026-03-09

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Memorial Sloan Kettering Cancer Center

Active not recruiting
11 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡